Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
2008
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
121
Citations
NaN
KQI